whatstheofficerproblem

Another component of SNDK's price action was degrossing from some pods. Momo names got slammed Friday & SNDK's correlation was 1. Risk police at pods would have never stood for that, the motto there is to sell first and ask questions later. We saw much of the same with Unity, 25% based on a fake tweet. Like I said in the inception letter, investors with duration will continue to win in a market dominated by quick money traders. This could be hard on the shorting end of things, but I don't plan on shorting names yet. Will always be open to shorting MRNA, but to short other stocks will require a ton of due diligence and next thing you know some pod is chasing it higher.

I ultimately did not pull the trigger on more SNDK Friday because I knew a better opportunity would arrive, I think a good amount of the price action on Friday was WDC selling part of their stake or entirety of it. Won't know until & unless they file which would be 45 days. It is still very cheap, I don't think it's going any lower after Jensen's comments a few hours ago.

Oh damn. Recurrence? I never knew he was diagnosed once before.

SNDK still 7% of the portfolio after reduction. EPS est for 2027 tightened to $80-100. Very bullish channel checks into 2028. Will add tomorrow.

I decreased the SNDK position considerably, didn't want to go into earnings with it. SNDK model highly levered to prices, even if you double Q1 which rest of the year doing 20%s will still get us to a quarterly run-rate EPS runrate above $25. SNDK's case in particular mixshift to eSSD has compounding effects but I'd rather buy more after call. JPM was pumping Kioxia the other day saying they had more market share than SNDK.

This account gained surprising traction in fintwit for the time it's been around. So seems like there is an environment of 'professional hating' going on in the space right now.

Don't reduce it to just the sun. The desert terrain, the plateaus, mesas & the purple hue of evening sky. Sometimes makes me wonder if that is what Mars looks like.

Depressing weather. I stepped away from a job at Amazon for this reason. I would have ended it if I was in Seattle. I need the sun, and a shit ton of it. Maybe Arizona spoiled me.

The worst part about Himalaya is that their office is in Seattle. I would find it very hard to perform in that state.

Looks like the record was made on the first 6-10 years where they 10x'd and the remainder 20 years were mediocre. Goes to show how much a few homeruns can impact overall performance.

I am surprised that Apollo Asia Fund has not been mentioned elsewhere on the forum. Perf is ridiculous, they outperformed Buffet.

As a fellow fund manager, I do not condone taking shots at others. But this has me wheezing.

I have this on sharesight, part of the reason there is no cash is it wouldn't let me add cash. I'm gonna post the reports here every month with letter every Q.

Yep, didn't want to overthink on a name for a trial fund. Also helps with my anonymity though some of the folks who have a ton of back on forth with me on here know my identity.

All this and I've been following LQDA for 3+ years now and know the mgmt, while CVRX is still a relatively newer name.

Biotech in general is very volatile. CVRx more so as it is a small cap and can move on little volume. The base distinction comes down to this, if the lawsuit goes our way, LQDA is a 3.5-4x by YE. That alone will drive a ~100% gain in the portfolio, CVRX is maybe a 2-3x from here plus the runway for this company is wide. They need to prove their story, payors take time to update and then their study will run for 3-4 years. There will be more opportunities to buy CVRx, maybe not for as cheap as $5, but cheap enough. LQDA on the other hand will hockey stick. If the suit goes our way, I plan on rotating more money into the company as I wouldn't want to let go of 'free money'. Factor is also an issue, drawdown on LQDA will likely only happen if the suit goes against the company whereas CVRx much more volatile and I do not know if it'll start selling off again once news of the trial starts to get jaded at which point I would buy more of it.

Why not . I'm very open to it, South Park helped me learn about this country when Boston Legal sold me the American dream. If anyone here knows Matt & Trey, put us in touch.

100%. One of the best there is. We were expecting the call to be a dumpster fire anyways. Have been long AMD for a year at this point, so naturally became the defacto CPU shortage bet. 1600 bps of Prem's cash .

Thank you. Please find the attached document. Tegridy Inception Letter.pdf

Ok, I think we have enough momentum to keep this going. Do not worry, I'm not raising capital. But as a fun exercise, I'm going to run a play pretend fund called Tegridy Value. Anyone have recommendations for paper portfolio platform? Going to post about positions etc here including quarterly letters. The fee structure will be 1-20. Number of positions will be capped at 10. Mandate is not restricted to US equities or any single sector.

Truly unfortunate she had to experience that. Re: Conspiracy theory, cue US foreign policy.

If you're referring to my handful recommendations as a reply to @sleepydragon, it's in the LQDA thread, I sent them to you.

But I do find great comfort knowing folks in here think I will be able to do it eventually. Thanks guys!

Survivorship bias. Also, times were different. If any of the big fund founders were to set up a fund today, they would never be as successful. The competition for capital is very intense. Market also has 0 duration in a way that only group think gets rewarded in the meantime.

Well, I'm from southern India, we've had a case like the Delhi one gfp mentioned as well. This is another fault line that is being exploited these days. People from the south hating on their fellow countrymen for validation online. Not realizing that the racists aren't laughing with them but at them. End of the day you'll still be Indian and they don't seem to understand that. The A's plan to balkanize India is materializing in real time.